Dividends Calendar Earnings Calendar
SYRS

SYRS | Syros Pharmaceuticals

Syros Pharmaceuticals
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 293.21M
  • Prev closed: 5.62
  • Open: 5.69
  • High: 5.69
  • Low: 5.06
  • 52 week low: 4.75
  • 52 week high: 15.65
  • Dividends:No Dividends

Next ER: August 5, 2021  Before Market Opens



Top Stories (SYRS)

    Company Profile

    Syros is redefining the power of small molecules to control the expression of genes with the aim of providing a profound benefit for patients. We are advancing a pipeline of gene control medicines for cancer and monogenic diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 5, 2021-0.36 / -0.375.16M / 4.13MBeat!
    May 6, 2021-0.23 / -0.46434.83M / 2.67MBeat!
    March 4, 2021-0.62 / -0.49885.7M / 2.64MBeat!
    November 5, 2020-0.43 / -0.3853.83M / 2.54MBeat!
    August 6, 2020-0.38 / -0.43.19M / 1.9MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Sep 17, 2021 5.080 5.070
    5.220
    4.655
    2.18M -6.79%
    Sep 16, 2021 5.450 5.230
    5.480
    5.100
    462.61K 4.01%
    Sep 15, 2021 5.240 5.260
    5.320
    5.160
    374.23K -0.38%
    Sep 14, 2021 5.260 5.250
    5.420
    5.220
    433.56K 0.57%
    Sep 13, 2021 5.230 5.070
    5.420
    4.870
    495.65K 3.16%
    Sep 10, 2021 5.070 5.320
    5.320
    5.050
    600.30K -3.98%
    Sep 9, 2021 5.280 5.200
    5.420
    5.160
    401.92K 0.76%
    Sep 8, 2021 5.240 5.481
    5.490
    5.170
    393.35K -3.68%
    Sep 7, 2021 5.440 5.300
    5.640
    5.297
    466.27K 2.64%
    Sep 3, 2021 5.300 5.490
    5.490
    5.200
    413.15K -4.5%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2011
    • Employees:76

    News

    News for (SYRS)

    This company doesn't provide a dividend.

    Key Persons

    • CFO :  Joseph J. Ferra
    • Chief Medical Officer :  David A. Roth

    Talk about Syros Pharmaceuticals below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 5, 2021 (Same day)

    znga syna sq gpro clls trip w z k lamr expe y 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedIn

    Other stocks 

    adsk s ual urbn snx df arrs gsat veev rh avgo five 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.